Jason Hsu
CIK: 0001895035
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Immix Biopharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 22, 2026IMMX
Immix Biopharma, Inc.
Award(A)Direct6.3K shares- - Jun 20, 2025IMMX
Immix Biopharma, Inc.
Award(A)DirectStock Option (Right to Buy)
33K shares- - Dec 23, 2024IMMX
Immix Biopharma, Inc.
Purchase(P)Direct40K shares at avg. $2.19$88K - Dec 20, 2024IMMX
Immix Biopharma, Inc.
Purchase(P)Direct7.7K shares at avg. $2.17$17K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 22, 2026 | IMMX Immix Biopharma, Inc. | Award(A) | 6,250 | - | $0 | Direct |
| Jun 20, 2025 | IMMX Immix Biopharma, Inc. | Award(A) Stock Option (Right to Buy) | 33,000 | - | - | Direct |
| Dec 23, 2024 | IMMX Immix Biopharma, Inc. | Purchase(P) | 40,000 | $2.19 | $87,680 | Direct |
| Dec 20, 2024 | IMMX Immix Biopharma, Inc. | Purchase(P) | 7,700 | $2.17 | $16,678 | Direct |
1-4 of 4 transactions
About Hsu Jason
Hsu Jason (SEC CIK 0001895035) files insider reports with the SEC as Director of Immix Biopharma, Inc. (IMMX).
Signal8 holds 3 ownership filings by Hsu Jason, all Form 4s, filed between Dec 26, 2024 and May 29, 2026. Those filings report 4 transactions, from Dec 20, 2024 to May 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hsu Jason's filings is in LOS ANGELES, CA.
Recent filings by Hsu Jason
Other insiders filing for Immix Biopharma, Inc. (IMMX)
- Adams Helen C., Director
- Ng Carey, Director
- Marquet Magda, Director
- Morris Gabriel S, CFO, President
- CHANG NANCY T, Director
- Rachman Ilya M, CEO and Chairman